MARK R HEMMILA, MD
Radiology in Ann Arbor, MI
License number
Michigan 4301063960
Category
Radiology
Type
Surgery
License number
Michigan 4301063960
Category
Radiology
Type
Surgical Critical Care
Address
Address
1500 Floor Taubman Ctr, Ann Arbor, MI 48109
Phone
(734) 936-5738
(734) 936-2047
(734) 936-2047
Personal information
See more information about MARK R HEMMILA at radaris.comName
Address
Phone
1203 Hutchins Ave, Ann Arbor, MI 48103
121 Cedar Ln, Negaunee, MI 49866
3310 Woodhill Cir, Ypsilanti, MI 48198
121 Cedar Ln, Negaunee, MI 49866
121 Cedar St, Negaunee, MI 49866
Professional information
See more information about MARK R HEMMILA at trustoria.com
Dr. Mark R Hemmila, Ann Arbor MI - MD (Doctor of Medicine)
Dr. Mark R Hemmila, Ann Arbor MI - MD (Doctor of Medicine)
Specialties:
Critical Care Surgery
Address:
University Michigan Medical Center
1500 E Medical Center Dr, Ann Arbor 48109
(734) 936-4179 (Phone)
University Michigan Medical Center SGY
1500 E Medical Center Dr, Ann Arbor 48109
(734) 936-5823 (Phone)
1500 E Medical Center Dr, Ann Arbor 48109
(734) 936-4179 (Phone)
University Michigan Medical Center SGY
1500 E Medical Center Dr, Ann Arbor 48109
(734) 936-5823 (Phone)
Certifications:
Critical Care Surgery, 2011, General Surgery, 2002
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
University Michigan Medical Center
1500 E Medical Center Dr, Ann Arbor 48109
University Michigan Medical Center SGY
1500 E Medical Center Dr, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
1500 E Medical Center Dr, Ann Arbor 48109
University Michigan Medical Center SGY
1500 E Medical Center Dr, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
Education:
Medical School
University Of Michigan Medical School
Graduated: 1994
University Mi
Graduated: 1995
Graduated: 2001
Graduated: 2002
University Of Michigan Medical School
Graduated: 1994
University Mi
Graduated: 1995
Graduated: 2001
Graduated: 2002
Mark R Hemmila, Ann Arbor MI
Mark R Hemmila, Ann Arbor MI
Specialties:
Surgeon
Address:
1500 E Medical Center Dr, Ann Arbor, MI 48109
Board certifications:
American Board of Surgery Certification in Surgery, American Board of Surgery Sub-certificate in Surgical Critical Care (Surgery)
Mark Richard Hemmila, Ann Arbor MI
Mark Richard Hemmila, Ann Arbor MI
Specialties:
Surgery, Surgical Critical Care, Critical Care Medicine
Work:
C.S. Mott Children's Hospital
1500 E Medical Center Dr, Ann Arbor, MI 48109
1500 E Medical Center Dr, Ann Arbor, MI 48109
Education:
University of Michigan Medical School (1994)
Nanoemulsion Therapeutic Compositions And Methods Of Using The Same
Nanoemulsion Therapeutic Compositions And Methods Of Using The Same
US Patent:
2010020, Aug 12, 2010
Filed:
Sep 25, 2009
Appl. No.:
12/567571
Inventors:
Mark R. Hemmila - Superior Township MI, US
Stewart C. Wang - Ann Arbor MI, US
Tarek Hamouda - Milan MI, US
John J. LiPuma - Ann Arbor MI, US
Jessica A. Knowlton - Ypsilanti MI, US
Paul E. Makidon - Webberville MI, US
Luz P. Blanco - Ann Arbor MI, US
Anna U. Bielinska - Ypsilanti MI, US
Stewart C. Wang - Ann Arbor MI, US
Tarek Hamouda - Milan MI, US
John J. LiPuma - Ann Arbor MI, US
Jessica A. Knowlton - Ypsilanti MI, US
Paul E. Makidon - Webberville MI, US
Luz P. Blanco - Ann Arbor MI, US
Anna U. Bielinska - Ypsilanti MI, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
A61K 9/107, A61K 39/02, A61P 31/04
US Classification:
424484, 4242341, 4241901
Abstract:
The present invention relates to therapeutic nanoemulsion compositions and to methods of utilizing the same. In particular, nanoemulsion compositions are described herein that find use in the treatment and/or prevention of infection (e.g., respiratory infection (e.g., associated with cystic fibrosis)), in burn wound management, and in immunogenic compositions (e.g., comprising a antigen) that generate an effective immune response (e.g., against a bacterial species of the genus ) in a subject administered the immunogenic composition. Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine), industrial, and research applications.